Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Mirvaso in Use Study

ClinicalTrials.gov ID: NCT02249065

Public ClinicalTrials.gov record NCT02249065. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 5:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)

Study identification

NCT ID
NCT02249065
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Galderma R&D
Industry
Enrollment
205 participants

Conditions and interventions

Conditions

Interventions

  • Brimonidine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2014
Primary completion
Jul 31, 2015
Completion
Jul 31, 2015
Last update posted
Jul 31, 2022

2014 – 2015

United States locations

U.S. sites
12
U.S. states
8
U.S. cities
12
Facility City State ZIP Site status
Johnson Dermatology Fort Smith Arkansas 72916
Blue Harbor Dermatology Newport Beach California 92663
Center for Dermatology and Laser Surgery Sacramento California 95819
Redwood Dermatology Research Santa Rosa California 95403
Florida Academic Dermatology Center Miami Florida 33136
Research Institute of the Southeast West Palm Beach Florida 33401
Grekin Skin Institute Warren Michigan 48088
Advanced Skin Research Center Omaha Nebraska 68144
Manhattan Dermatology and Cosmetic Surgery New York New York 10017
DermDox Centers for Dermatology Hazleton Pennsylvania 18201
Arlington Research Center Arlington Texas 76011
Texas Dermatology and Laser Specialists San Antonio Texas 78218

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02249065, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 31, 2022 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02249065 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →